EverHint – EMA 10 + Price + MACD – Top 13 Signals for Jun 23, 2026
13 signals. Healthcare leads (3). price range $19-$239. 1 with insider buying. 2 with insider selling.
What This Signal Is
Experimental strategy combining price crossing above EMA10 from below with MACD Line crossing above Signal Line from below. Both conditions must occur on the same day for a signal, providing double confirmation and higher-quality setups.
Entry Criteria:
- Buy: Price > EMA10 AND MACD line crosses above signal line
- Sell: Price < EMA10 AND MACD line crosses below signal line
- Minimum ADV: $40M (liquidity filter)
- Earnings buffer: 7 days pre/post earnings
- Fresh signal: All conditions met on today's close
Holding period: 1-3 weeks | Risk level: Medium-High
Market Context
The sharp divergence between indices on June 23rd tells an important story: the Nasdaq's steep 2.21% decline versus the Dow's near-flat session suggests a clear rotation away from growth and technology-heavy names toward more defensive, value-oriented positions. This kind of spread typically signals risk-off sentiment taking hold, where momentum-driven strategies like EMA/MACD crossovers may face headwinds from choppy, mean-reverting price action rather than clean directional trends. Traders relying on trend-following signals should be cautious, as these environments can produce false breakouts and whipsaw entries.
The VIX spike of over 12% to 19.39 is a significant development. While not yet at "fear" territory above 25, this level of single-day volatility expansion warns of elevated intraday price swings that can widen spreads, trigger stop-losses prematurely, and reduce the reliability of short-term EMA signals. For the 13 signals generated today, position sizing and risk management become especially critical — the same signal that works cleanly in a low-VIX environment carries meaningfully more execution risk here.
Healthcare emerging as the top signal sector aligns well with the defensive rotation implied by the broader index divergence. Healthcare tends to attract capital during uncertain, risk-off sessions due to its relatively stable earnings profile and lower sensitivity to economic cycles. EMA and MACD signals firing within this sector may carry higher conviction than those in more volatile growth sectors today, making Healthcare-focused signals worth prioritizing while broader market direction remains unsettled.
🟢 Buy Signals (13 of 13 total)
Ranked by RSI (lower RSI = more oversold for buy signals)
| # | Ticker | Company | Sector | Price | Insider | MCap |
|---|---|---|---|---|---|---|
| 1 | AZN | AstraZeneca PLC | Healthcare | $181.02 | -$24,176 | $280.7B |
| 2 | DEO | Diageo plc | Consumer Defensive | $82.24 | — | $45.7B |
| 3 | JNJ | Johnson & Johnson | Healthcare | $239.08 | — | $575.5B |
| 4 | LNG | Cheniere Energy, Inc. | Energy | $234.22 | — | $49.1B |
| 5 | MKC | McCormick & Company, I... | Consumer Defensive | $47.38 | -$16,451 | $12.7B |
| 6 | NNN | NNN REIT, Inc. | Real Estate | $46.02 | — | $8.8B |
| 7 | NVS | Novartis AG | Healthcare | $153.38 | — | $292.7B |
| 8 | OHI | Omega Healthcare Inves... | Real Estate | $46.41 | — | $13.8B |
| 9 | RSG | Republic Services, Inc. | Industrials | $209.10 | +$47,132,699 | $64.3B |
| 10 | SBRA | Sabra Health Care REIT... | Real Estate | $18.63 | — | $4.7B |
| 11 | TFC | Truist Financial Corpo... | Financial Services | $49.67 | — | $61.9B |
| 12 | TSN | Tyson Foods, Inc. | Consumer Defensive | $57.42 | — | $20.4B |
| 13 | WM | Waste Management, Inc. | Industrials | $218.84 | — | $87.9B |
Field Notes
Sector concentration: Healthcare (3), Consumer Defensive (3), Real Estate (3)
Insider selling: AZN (AstraZeneca PLC, -$24,176), MKC (McCormick & Company, Incorporated, -$16,451)
Insider buying: RSG (Republic Services, Inc., +$47,132,699)
Data coverage: 46.2% insider, 23.1% congressional, 0.0% earnings, 15.4% news
Peer Analysis
LNG (Cheniere Energy, Inc.): Leads 5 peers: OKE ($88.06), MPLX ($57.68), SU ($56.50), IMO ($114.64), TRP ($69.41)
NNN (NNN REIT, Inc.): Leads 5 peers: ADC ($74.37), FRT ($123.68), REG ($78.67), NTST ($19.92), KIM ($25.19)
TFC (Truist Financial Corporation): Leads 5 peers: USB ($60.05), PNC ($238.67), KEY ($23.02), ZION ($68.49), FITB ($54.67)
NVS (Novartis AG): Leads 5 peers: AZN ($181.02), GSK ($52.07), BMY ($55.53), SNY ($41.60), MRK ($119.60)
MKC (McCormick & Company, Incorporated): Leads 5 peers: TSN ($57.42), USFD ($94.01), HRL ($24.72), KOF ($107.00), BG ($110.86)
Congressional Activity
WM (Waste Management, Inc.) 🔴 Bearish
- 1 sale by 1 member
DEO (Diageo plc) 🔴 Bearish
- 1 sale by 1 member
JNJ (Johnson & Johnson) 🟢 Bullish
- 1 purchase by 1 member
Recent Headlines
AZN (AstraZeneca PLC)
- Astrazeneca (AZN) Stock Drops Despite Market Gains: Important Facts to Note
RSG (Republic Services, Inc.)
- Republic Services Breaks Ground on San Bernardino Sustainability Park
- Forget WM: As June Macro Volatility Shakes Wall Street, This Stock Is a No-Brainer Buy
Vlad's Take
Today's signals: Strong sector concentration in Healthcare (3 signals) suggests sector-specific rotation. 1 signal with insider buying adds conviction. 2 signals with congressional selling warrant attention.
Independent, data-driven signals.
No hype. No promotions. Just experimental market research from EverHint.
👉 This is not financial advice. Market conditions change rapidly.
Do your own due diligence.
📢 If this added value to your research, consider liking, sharing, or subscribing. It genuinely helps.